Lidovyx

Manufacturer
V2 Pharma LLC
Effective date
2026-06-30
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
weekly-update
Hydrated at
2026-07-17 21:41:47

Label at a glance#

ProductLidovyx
Active ingredientLIDOCAINE HYDROCHLORIDE
Label structure11 sections

Indications and uses

For the temporary relief of pain and itching 

Dosage and administration

Adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily Children under 2 years of age: do not use, consult a physician

Storage and handling

Protect this product from excessive heat and direct sun.

Label contents#

Full prescribing information#

Lidovyx

SPL UNCLASSIFIED SECTION

Touch free targeted relief

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine HCL 4%

Purpose

OTC - PURPOSE SECTION

Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

For the temporary relief of pain and itching 

Warnings

WARNINGS SECTION

For external use only

Avoid contact with eyes

Do not use in large quantities, particularly over raw surfaces or blistered areas

Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Discontinue use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily
  • Children under 2 years of age: do not use, consult a physician

Storage

STORAGE AND HANDLING SECTION

Protect this product from excessive heat and direct sun.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

water, SD alcohol 40-B, aloe barbadensis leaf extract, propylene glycol, triethanolamine, acrylates/C10-30 alkyl acrylate crosspolymer, glycerin, menthol, chamomile extract, calendula extract, green tea extract, comfrey extract, phenoxyethanol, ethylhexylglycerin

Other Information

SPL UNCLASSIFIED SECTION

Manufactured for V2 Pharma, LLC

8210 SW Nimbus Ave.

Beaverton, OR 97008

+1 (800) 519-8334

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Lidovyx 

NDC 72835-447-01

Lidovyx LabelLidovyx Label

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130372835447016GTIN-13: 0372835447016
EAN-13: 0372835447016
GTIN-12: 372835447016
UPC-A: 372835447016
GTIN storage (14 digits): 00372835447016
Lidovyx Label.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72835-44772835-447-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12026-06-25monthly-update2026-07-17 21:35:57

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LidovyxLIDOCAINE 4%V2 Pharma LLC4465eb60-a617-4608-9504-8b3b4c64f49e2026-06-30WarningsExact identifier
ndc (package): 72835-447-01
ndc (product): 72835-447
ndc11 (package): 72835044701
spl id: 6e720151-c3e3-4f59-a996-f652ad87b5a8
spl set id: 4465eb60-a617-4608-9504-8b3b4c64f49e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.